Arvinas, Inc. (ARVN)
NASDAQ·Healthcare·Biotechnology
$6.53
+1.79%
Mkt Cap $428.28M
Analyst Ratings
Buy
7
Hold
2
Sell
0
Price Target (40 analysts)
$14.17
Range $10.00 – $20.00
Implied Upside
+117.2%
Consensus $14.17 vs current $6.53
NASDAQ·Healthcare·Biotechnology
$6.53
+1.79%
Mkt Cap $428.28M
Buy
7
Hold
2
Sell
0
Price Target (40 analysts)
$14.17
Range $10.00 – $20.00
+117.2%
Consensus $14.17 vs current $6.53